Tether Buys $200M Majority Stake in Brain-Computer Interface Company Blackrock Neurotech
/arc-photo-coindesk/arc2-prod/public/LXF2COBSKBCNHNRE3WTK2BZ7GE.png)
Tether, the issuer of stablecoin USDT, said Monday that it invested $200 million to acquire a majority stake in brain-computer interface company Blackrock Neurotech via its venture capital division Tether Evo.
Blackrock Neurotech develops medical devices that are powered by brain signals and aims to help people impacted by paralysis and neurological disorders.
02:26
DOJ Wants CZ to Serve 3 Years in Prison; Tether to Freeze Wallets Evading Venezuelan Sanctions
02:17
Polymarket Traders Bet on Fed Rate Cuts; Bitcoin Spot ETFs Register Five-Day Withdrawals Streak
01:42
Bitcoin Starts Trading Week in the Red; Tether Freezes 41 Crypto Wallets Tied to Sanctions
01:03
El Salvador Targets Bitcoin Millionaires in New Push to Attract Long-Term Residents
The technology firm is not related to the asset management giant BlackRock.
The investment will fund the roll-out and commercialization of the medical devices and also for research and development purposes, the press release said.
Tether is the company behind USDT, the largest stablecoin with a market cap of $110 billion. Recently, Tether established four divisions to expand beyond stablecoin issuance.
“Tether has long believed in nurturing emerging technologies that have transformative capabilities, and the Brain-Computer-Interfaces of Blackrock Neurotech have the potential to open new realms of communication, rehabilitation, and cognitive enhancement,” Paolo Ardoino, CEO of Tether, said in a statement.
Edited by Parikshit Mishra.
